Onkure Therapeutics Inc

OKUR USD0.0001
Create an alert
Sell
$2.17
Buy
$2.29
No change
Last updated today at
Back to dashboard

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
21 September 2026
Jason A LeveroneCFO
Sell
Tax related
302$2.97$898.2118,500
21 September 2026
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
87$2.97$258.7611,160
22 June 2026
Jason A LeveroneCFO
Sell
Tax related
303$4.40$1,332.0818,802
22 June 2026
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
86$4.40$378.0811,247
23 March 2026
Jason A LeveroneCFO
Sell
Tax related
301$4.16$1,251.1116,000
23 March 2026
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
86$4.16$357.467,333
22 December 2025
Jason A LeveroneCFO
Sell
Tax related
302$2.97$896.2516,301
22 December 2025
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
87$2.97$258.197,419

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 June 2026
Jason A LeveroneCFO
Sell
Tax related
303$4.40$1,332.0818,802
23 March 2026
Jason A LeveroneCFO
Sell
Tax related
301$4.16$1,251.1116,000
21 September 2026
Jason A LeveroneCFO
Sell
Tax related
302$2.97$898.2118,500
22 December 2025
Jason A LeveroneCFO
Sell
Tax related
302$2.97$896.2516,301
22 June 2026
Nicholas A SaccomanoPresident/CEO
Sell
Tax related
86$4.40$378.0811,247

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.